Does coffee negatively impact heart health?

Moderate coffee consumption (3–5 cups per day) does not negatively impact heart health for most people and may offer protective benefits. Current research indicates a neutral-to-positive association with cardiovascular outcomes in the general population, supported by large-scale observational studies and meta-analyses.

Key Findings

• ·Coronary Heart Disease & Stroke: Moderate intake (3–5 cups/day) is linked to an 8–12% lower risk of coronary heart disease and stroke compared to non-drinkers, with a U-shaped relationship observed for heart failure (15–20% lower risk at 2–4 cups/day).
• ·Arrhythmias: Contrary to historical concerns, moderate coffee consumption does not increase atrial fibrillation risk for most individuals, though high intake (>5 cups/day) may pose a slight risk (OR ≈1.12) in some studies.
• ·Blood Pressure: Caffeine causes a temporary increase (3–5 mmHg systolic), but habitual consumption does not strongly correlate with chronic hypertension in normotensive individuals. Those with uncontrolled hypertension should monitor intake.
• ·Mortality: A J-shaped curve suggests lowest all-cause mortality at 2–3 cups/day, with risks rising only at excessive intake (>8 cups).

Important Nuances

• ·Preparation Matters: Unfiltered coffee (e.g., French press, Turkish) contains diterpenes (cafestol, kahweol) that can raise LDL cholesterol by 5–8%. Paper-filtered coffee removes these compounds.
• ·Genetic & Individual Factors: Slow caffeine metabolizers (CYP1A2 gene variants) or those with severe arrhythmias may need personalized limits.
• ·Additives: Benefits are tied to black coffee; added sugar/cream can negate cardiovascular advantages.

Recommendations

• ·General Adults: 3–5 cups/day of filtered coffee is safe and potentially beneficial.
• ·High-Risk Groups (e.g., uncontrolled hypertension, arrhythmia-prone): Limit to 1–2 cups/day and consult a cardiologist.
• ·Preparation Preference: Opt for filtered methods if LDL is a concern.

Note: Evidence is largely observational, though Mendelian randomization studies support safety.